|  Help  |  About  |  Contact Us

Publication : Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP<sup>+</sup>-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons.

First Author  Kawahata I Year  2019
Journal  Int J Mol Sci Volume  20
Issue  21 PubMed ID  31661838
Mgi Jnum  J:292847 Mgi Id  MGI:6451213
Doi  10.3390/ijms20215358 Citation  Kawahata I, et al. (2019) Fatty Acid-Binding Protein 3 is Critical for alpha-Synuclein Uptake and MPP(+)-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons. Int J Mol Sci 20(21):5358
abstractText  alpha-Synuclein is an abundant neuronal protein that accumulates in insoluble inclusions in Parkinson's disease and other synucleinopathies. Fatty acids partially regulate alpha-Synuclein accumulation, and mesencephalic dopaminergic neurons highly express fatty acid-binding protein 3 (FABP3). We previously demonstrated that FABP3 knockout mice show decreased alpha-Synuclein oligomerization and neuronal degeneration of tyrosine hydroxylase (TH)-positive neurons in vivo. In this study, we newly investigated the importance of FABP3 in alpha-Synuclein uptake, 1-methyl-4-phenylpyridinium (MPP(+))-induced axodendritic retraction, and mitochondrial dysfunction. To disclose the issues, we employed cultured mesencephalic neurons derived from wild type or FABP3(-/-) C57BL6 mice and performed immunocytochemical analysis. We demonstrated that TH(+) neurons from FABP3(+/+) mice take up alpha-Synuclein monomers while FABP3(-/-) TH(+) neurons do not. The formation of filamentous alpha-Synuclein inclusions following treatment with MPP(+) was observed only in FABP3(+/+), and not in FABP3(-/-) neurons. Notably, detailed morphological analysis revealed that FABP(-/-) neurons did not exhibit MPP(+)-induced axodendritic retraction. Moreover, FABP3 was also critical for MPP(+)-induced reduction of mitochondrial activity and the production of reactive oxygen species. These data indicate that FABP3 is critical for alpha-Synuclein uptake in dopaminergic neurons, thereby preventing synucleinopathies, including Parkinson's disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression